Abstract: This invention relates to a nonwoven material comprising an adhesive comprising polyhydroxyalkanoate (PHA). This invention also relates to an absorbent article comprising such nonwoven material. This invention also relates to a composition comprising PHA and a surfactant. This invention relates to a method for preparing the nonwoven material.

Abstract: Disclosed are anhydrous antiperspirant gel-solid sticks which comprise particulate antiperspirant active; a solid non-polymeric gellant that is substantially free of dibenzylidene alditol, inorganic thickening agents, organic polymeric gellants, amides and esters of N-acyl amino acid, or combinations thereof; an anhydrous liquid carrier that is substantially free of polar, water-immiscible, organic solvents, wherein the composition has a visible residue index of from about 11 to about 30 L-value, a product hardness of from about 500 to about 5,000 gram force, a rheology profile defined by a ratio of an elastic modulus (G') to a viscous modulus (G") of from about 0.1 to about 100. The refractive indices of the particulate antiperspirant active, the solid non-polymeric gellant, and the anhydrous liquid carrier are not matched. The compositions preferably comprise crystalline gellant particles having an average particle size of less than about 1 .mu.

Abstract: Disclosed are topical compositions comprising from about 0.01% to about 50% by weight of N-acetylcysteine or related compounds, from about 0.01% to about 0.5% by weight of selected combinations of certain perfume chemicals to effectively mask malodors associated with topical application of the N-acetylcysteine or related compounds on skin; and a cosmetically acceptable topical carrier. These topical compositions are useful for visibly improving the appearance of skin.

Abstract: The present invention relates to phosphonsulfonates and the pharmaceutically-acceptable salts and esters thereof, having the following structure according to formula (I): ##STR1## The present invention further relates to pharmaceutical compositions containing a safe and effective amount of a compound of the present invention, and pharmaceutically-acceptable excipients. Finally, the present invention relates to methods for treating or preventing pathological conditions characterized by abnormal calcium and phosphate metabolism in humans or other mammals, including treating or preventing osteoporosis and arthritis, especially rheumatoid arthritis and osteoarthritis. This method comprises administering to a human or other mammal in need of such treatment of a safe and effective amount of a compound or composition of the present invention.

Abstract: Disclosed are antiperspirant cream compositions which have a penetration force value of from about 20 gram.multidot.force to about 500 gram.multidot.force, and comprise (a) from about 20% to about 80% by weight of a volatile silicone material; (b) from about 5% to about 35% of a particulate antiperspirant active; and (c) from about 0.1% to about 20% by weight of a gellant material comprising glyceryl tribehenate and other triglycerides wherein at least about 75% of the esterified fatty acid moieties of said other triglycerides have from about 18 to about 36 carbon atoms, and the molar ratio of glyceryl tribehenate to said other triglycerides is from about 20:1 to about 1:1. The compositions preferably further comprise a residue masking material.

Abstract: Disclosed are hair conditioning compositions, including hair rinse and shampoo compositions, containing a silicone fluid hair conditioning compoentn with improved efficiency through the use of silicone resins, wherein the weight ratio of the silicone fluid component to silicone resin is from about 4:1 to about 400:1.

Abstract: The present invention provides a process for making a compound having a structure according to Formula (I) ##STR1## wherein A.sup.1, A.sup.2 and A.sup.3 are independently carbon or nitrogen and R.sup.1, R.sup.3, R.sup.4 and R.sup.6 are known quinolone substituents; and wherein one of R.sup.1, R.sup.3 or R.sup.6 may be a lactam-containing moiety;or a protected form, salt, pharmaceutically-acceptable salt, biohydrolyzable ester, or solvate thereof;the process comprising reacting one or more organosilicon compounds with a compound having a structure according to Formula (II) ##STR2## wherein A.sup.1, A.sup.2 and A.sup.3, R.sup.1, R.sup.3, R.sup.4 and R.sup.6 as described above; wherein one of R.sup.1, R.sup.3 or R.sup.6 may be a lactam-containing moiety; and X is a leaving group;or a protected form, salt, biohydrolyzable ester, or solvate thereof.

Abstract: Disclosed is a fiber comprising, chemically bonded together, (a) a conventional cellulosic fiber, such as a Kraft fiber or a chemithermomechanical pulp fiber; (b) poly(acrylate-co-itaconate) copolymer, such as the acid form of a poly(acrylate-co-itaconate) copolymer comprising 90-95 mole % acrylate and 5-10 mole % itaconate having weight average molecular weight of about 600,000-900,000; and (c) a polyol, such as polyethylene glycol; also disclosed are methods for making such fibers, especially evaporatively depositing an intimate mixture of the copolymer and polyol on the fiber followed by thermally crosslinking at specific temperatures for limited periods; absorbent paper which can be made by wet-laying the fiber, especially in admixture with conventional fiber; and derivative paper structures, such as multi-ply disposable absorbent towels.

Abstract: A method for generating new bone growth in a mammal comprising administrating to the mammal a safe and effective amount of a Vitamin D compound in combination with a safe and effective amount of osteoinductive extract or at least one BMP.

Abstract: The cyclic ureas, and the pharmaceutically-acceptable salts and esters thereof, of the present invention are useful as antiarrhythmic and antifibrillatory agents and have the following general structure: ##STR1## wherein X, Y, A, L, R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are defined as in the Specification.

Abstract: The subject invention involves compounds having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl;(b) R' is selected from hydrogen; unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; unsubstituted C.sub.1 -C.sub.3 alkylthio or alkoxy; hydroxy; thiol; cyano; and halo; and(c) R" is selected from hydrogen, methyl, ethyl and i-propyl.The subject invention also involves pharmaceutical compositions containing such novel compounds, compositions thereof and the use of such compounds for preventing or treating respiratory, ocular and/or gastrointestinal disorders.

Abstract: A make-up composition in the form of a water-in-off emulsion comprising a silicone phase, humectanct, pigment and organic amphiphilic material capable of forming smectic lyotropic liquid crystals in product or on the skin. The make-up composition exhibits superior short and longer term moisturisation and skin feel, together with improved product stability and spreadability.

Abstract: This invention relates to a nonwoven material comprising an adhesive comprising polyhydroxyalkanoate (PHA). This invention also relates to an absorbent article comprising such nonwoven material. This invention also relates to a composition comprising PHA and a surfactant. This invention further relates to a method for preparing the nonwoven.

Abstract: The present invention is for powder compositions containing high levels of talc, low levels of titanium dioxide and a sebum absorbing material wherein the composition has improved skin coverage, uniformity and duration of wear. The invention can be used in formulating numerous cosmetic powder compositions such as eye shadow, foundation, loose powder and the like.

Abstract: The subject invention relates to desquamation compositions comprising a combination of sulfhydryl compounds and zwitterionic surfactants. The subject invention further relates to methods of desquamation in mammalian skin and treating acne in mammalian skin.

Abstract: Antimicrobial dithiocarbamoyl quinolone compounds of the general formula: ##STR1## wherein (1) A.sup.1, A.sup.2, A.sup.3, R.sup.1, R.sup.3, R.sup.4, and R.sup.6 form any of a variety of quinolone and related heterocyclic structures similar to those known in the art to have antimicrobial activity; and(2) (1) R.sup.1 is X, R.sup.3 is X, or both R.sup.1 and R.sup.3 are X; and X is the dithiocarbamate containing moiety;and pharmaceutically-acceptable salts and biohydrolyzable esters thereof, and hydrates thereof.

Abstract: The present invention relates to compounds that exhibit inhibitory activity against matrix metalloproteases ("MMPs"). Because MMPs are known to play a role in tissue degradation, the compounds of the present invention may be useful in preventing or treating diseases associated with excess MMP activity. In particular, the compounds have a structure according to Formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are various substituents as described in the specification; and Q is an alkyl chain, an alkenyl chain, a heteroalkyl chain, or a heteroalkenyl chain, wherein said chain has 2, 3, or 4 chain atoms and is unsubstituted or substituted with one or more alkyl moieties; or a pharmaceutically-acceptable salt, or biohydrolyzable alkoxyamide, acyloxyamide, or imide thereof. Preferred are those compounds where Q is an alkyl chain having 2, 3 or 4 chain atoms.

Abstract: The present invention relates to methods of inhibiting alveolar bone resorption or the undesirable movement of teeth of a human or other animal comprising:a) administering a reservoir to the gingival tissue of the oral cavity such that the reservoir is in contact with the exposed tissue nearest to the alveolar bone to be treated wherein the reservoir is a composition having a pH which maintains an active compound in a negatively charged state and comprises a safe and effective amount of the active compound having the structure: ##STR1## wherein: n is an integer from 0 to 7 (preferably from 0 to 3, more preferably 1); R.sup.1 is hydrogen, chloro, amino, or hydroxy (preferably hydrogen or hydroxy); X is --NH--, quaternary amine, oxygen, sulfur, or a single bond (preferably --NH-- or single bond); R.sup.

Abstract: The compositions of the present invention are useful for the topical delivery of a wide variety of active ingredients. These compositions are particularly useful for treating conditions such as acne and its attendant skin lesions, blemishes, and other imperfections. These compositions are nonirritating to the skin and also provide improved skin feel benefits. These compositions can be in the form of leave-on products and products that are rinsed or wiped from the skin after use.

Abstract: The present invention is for powder compositions having high levels of talc and low levels of titanium dioxide wherein said compositions have improved skin coverage and uniformity. Said compositions comprise talc wherein said talc comprises a first talc having a particle size distribution wherein no more than about 45% of the particles are 10 microns or less; no more than about 70% of the particles are 15 microns or less and no more than about 75% of the particles are 20 microns or less and a second talc having a particle size distribution wherein no less than about 75% of the particles are 10 microns or less, no less than about 90% of the particles are 15 microns or less and no less than about 95% of the particles are 20 microns or less. The ratio of said first talc to said second talc is from about 1:1 to about 6:1. The invention can be used in formulating numerous cosmetic powder compositions such as eye shadow, foundation, loose powder and the like.